XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Equity
6 Months Ended
Jun. 30, 2025
Equity  
Equity

14. Equity

The changes in shareholders’ equity for the three and six months ended June 30, 2025 were as follows:

Additional

Accumulated Other

Total

Common Stock

 

Paid- In

Treasury Stock

Accumulated

 

Comprehensive

Shareholders’

   

Shares

   

Amount

   

Capital

   

Shares

   

Amount

   

Deficit

   

Income (Loss)

   

Equity

Balance, December 31, 2024

39,646,749

$

40

$

590,251

(8,206,594)

$

(197,505)

$

(163,999)

$

55

$

228,842

Exercise of common stock options

67,718

1,552

1,552

Issuance for employee stock purchase plan

17,868

506

506

Vesting of RSUs and PSUs

956,368

Shares withheld for employee taxes upon vesting of RSUs and PSUs

(350,311)

(10,593)

(10,593)

Stock-based compensation

11,524

11,524

Other comprehensive loss, net of tax

186

186

Net income

2,417

2,417

Balance, March 31, 2025

40,338,392

$

40

$

593,240

(8,206,594)

$

(197,505)

$

(161,582)

$

241

$

234,434

Exercise of common stock options

21,944

308

308

Vesting of RSUs and PSUs

102,760

Shares withheld for employee taxes upon vesting of RSUs and PSUs

(14,949)

(428)

(428)

Share repurchases from Accelerated Share Repurchase ("ASR") agreement

(5,000)

(692,281)

(20,005)

(25,005)

Stock-based compensation

10,818

10,818

Other comprehensive loss, net of tax

96

96

Net income

11,983

11,983

Balance, June 30, 2025

40,448,147

$

40

$

598,938

(8,898,875)

$

(217,510)

$

(149,599)

$

337

$

232,206

The changes in shareholders’ equity for the three and six months ended June 30, 2024 were as follows:

Additional

Accumulated Other

    

Total

Common Stock

 

Paid- In

Treasury Stock

Accumulated

Comprehensive

 

Shareholders’

   

Shares

   

Amount

   

Capital

   

Shares

   

Amount

   

Deficit

   

Income (Loss)

   

Equity

Balance, December 31, 2023

38,192,441

$

38

$

565,949

(6,323,892)

$

(137,381)

$

(233,189)

$

14

$

195,431

Exercise of common stock options

200,200

4,205

4,205

Issuance for employee stock purchase plan

18,538

356

356

Vesting of RSUs and PSUs

1,000,357

1

1

Shares withheld for employee taxes upon vesting of RSUs and PSUs

(381,897)

(12,874)

(12,874)

Stock-based compensation

7,475

7,475

Other comprehensive loss, net of tax

(138)

(138)

Net income

27,713

27,713

Balance, March 31, 2024

39,029,639

$

39

$

565,111

(6,323,892)

$

(137,381)

$

(205,476)

$

(124)

$

222,169

Exercise of common stock options

282,248

1

5,727

5,728

Vesting of RSUs and PSUs

392,140

1

1

Shares withheld for employee taxes upon vesting of RSUs and PSUs

(171,669)

(1)

(5,874)

(5,875)

Share repurchases from ASR agreement

(7,000)

(888,889)

(28,000)

(35,000)

Stock-based compensation

10,012

10,012

Other comprehensive loss, net of tax

(58)

(58)

Net income

19,606

19,606

Balance, June 30, 2024

39,532,358

$

40

$

567,976

(7,212,781)

$

(165,381)

$

(185,870)

$

(182)

$

216,583

Common Stock

In May 2015, the Company adopted the Amended and Restated 2014 Stock Incentive Plan (the “Plan”), under which an aggregate of 2,700,000 shares of common stock were authorized for issuance to employees, officers, directors, consultants and advisors of the Company, plus an annual increase on the first day of each fiscal year until the expiration of the Plan equal to 4% of the total number of outstanding shares of common stock on December 31st of the immediately preceding calendar year (or a lower amount as otherwise determined by the Company’s board of directors (“Board of Directors”) prior to January 1st). The Plan expired on May 11, 2025 and on May 15, 2025, the Company’s shareholders approved the 2025 Equity Incentive Plan (the “2025 Plan”), under which an aggregate of 1,600,000 shares of common stock were authorized for issuance to employees, officers, directors, consultants and advisors of the Company, plus (i) shares of common stock that remained available for grants under the Plan as of its expiration and (ii) any shares of common stock subject to outstanding grants under the Plan that terminate, expire or are canceled, forfeited, exchanged or surrendered without having been exercised, vested or paid under the Plan. As of June 30, 2025, there were 3,329,549 shares of common stock available for issuance pursuant to the 2025 Plan.

The 2025 Plan provides for granting of both Internal Revenue Service qualified incentive stock options and non-qualified options, restricted stock awards, restricted stock units and performance stock units. The Company’s qualified incentive stock options and non-qualified options generally vest ratably over a four-year period of service and generally have a ten-year contractual life. Upon termination, vested stock options are generally exercisable for three months following the termination date, while unvested options are forfeited immediately upon termination. The Company’s RSUs granted prior to 2024 generally vest ratably over a four-year period of service. Beginning in 2024, RSUs granted by the Company vest ratably over a three-year period of service. Upon termination, unvested RSUs are forfeited immediately. Refer to Note 15, Stock-based Compensation, for more information.

Share Repurchases

2024-2025 Repurchase Program

In January 2024, the Company’s Board of Directors authorized the repurchase of up to $150,000 of the Company’s common stock through June 30, 2025 (the “2024-2025 Repurchase Program”). The 2024-2025 Repurchase Program permitted the Company to effect repurchases through a variety of methods, including open-market purchases (including pursuant to a trading plan adopted in accordance with Rule 10b5-1 of the Exchange Act), privately negotiated transactions, or otherwise in compliance with Rule 10b-18 of the Exchange Act. The timing and amount of any shares purchased on the open market were determined based on the Company’s evaluation of the market conditions, share price and other factors. The Company utilized existing cash on hand to fund share repurchases.

In May 2025, the Company’s Board of Directors authorized an accelerated share repurchase (“ASR”) program to repurchase $25,000 of the Company’s common stock as part of the 2024-2025 Repurchase Program. Under the terms of the Company's ASR agreement with an investment bank, the Company paid $25,000 on May 9, 2025, and received 692,281 shares, representing 80% of the upfront payment on a price per share of $28.89, the closing price on the date the agreement was executed. The remaining shares to be purchased by the Company was to be based on the volume-weighted average price of its common stock through July 29, 2025, minus an agreed upon discount between the parties. In July 2025, the ASR agreement settled and the Company received an additional 129,847 shares, bringing the total shares repurchased pursuant to the ASR agreement to 822,128.

The ASR agreement was accounted for as two distinct transactions: (1) an immediate repurchase of common stock, recorded as a treasury stock transaction; and (2) a forward contract indexed to the Company’s own stock. The forward contract, which represented the remaining shares to be delivered by the investment bank, was recorded as a reduction to stockholders’ equity as of June 30, 2025. The forward contract associated with the ASR agreement was outstanding as of June 30, 2025.

The 2024-2025 Repurchase Program expired on June 30, 2025. Through June 30, 2025, the Company repurchased 2,574,983 shares at a weighted-average price of $31.08 per share for a total of $80,025, inclusive of $25 of fees and commissions, under the 2024-2025 Repurchase Program and the cost of repurchased shares was recorded as treasury stock in the Condensed Consolidated Balance Sheet. As of June 30, 2025, $5,000 of share repurchases under the May 2025 ASR remain to be delivered and $65,000 remained available for share repurchases under the 2024-2025 Repurchase Program upon expiration.

2025-2026 Repurchase Program

In July 2025, the Company’s Board of Directors authorized the repurchase of up to $150,000 of the Company’s common stock through December 31, 2026 (the “2025-2026 Repurchase Program”) (refer to Note 2, Summary of Significant Accounting Policies - Subsequent Events). The 2025-2026 Repurchase Program permits the Company to effect repurchases through a variety of methods, including open-market purchases (including pursuant to a trading plan adopted in accordance with Rule 10b5-1 of the Exchange Act), privately negotiated transactions, or otherwise in compliance with Rule 10b-18 of the Exchange Act. The timing and amount of any shares purchased on the open market will be determined based on the Company’s evaluation of the market conditions, share price and other factors. The Company plans to utilize existing cash on hand to fund share repurchases.